AGT and COVID-19: Herein, we focus on the role of angiotensin II (AngII), a vasopressor peptide of the RAS, in CVDs and examine how its upregulation might contribute to the underlying pathology of COVID-19, especially in individuals who have one or more cardiovascular comorbidities and are at a greater risk of developing severe disease.